Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
oleh: Brittany K. Smith, Andrew B. Janowski, Arim C. Fremont, Lucas J. Adams, Ya-Nan Dai, Christopher W. Farnsworth, Ann M. Gronowski, Stephen M. Roper, David Wang, Daved H. Fremont
| Format: | Article |
|---|---|
| Diterbitkan: | American Society for Microbiology 2021-08-01 |
Deskripsi
This study determined the percentage of children and adult samples from the St. Louis metropolitan area in Missouri with SARS-CoV-2 antibodies during three collection periods spanning April 2020 to January 2021. By January 2021, 20.68% of the tested individuals had antibodies. These results show the evolution of the SARS-CoV-2 pandemic in St. Louis, Missouri, and provide a snapshot of the extent of infection just prior to the start of mass vaccination.